American Capital Advisory’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
American Capital Advisory's PCVX Position: Q3 2026 in Review
American Capital Advisory sold out of Vaxcyte (PCVX) in Q3 2026, closing a stake of 1 share — an estimated $59 sold.
American Capital Advisory first reported a position in PCVX in Q1 2026 and held it in 2 quarters. The position peaked at $59 in Q2 2026. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- American Capital Advisory reported no remaining Vaxcyte position as of Q3 2026 after selling out during the quarter.
- American Capital Advisory sold 1 Vaxcyte share in Q3 2026, an estimated $59.
- American Capital Advisory first reported a position in Vaxcyte in Q1 2026 and held it in 2 quarters.
- American Capital Advisory's Vaxcyte position peaked at $59 in Q2 2026.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on American Capital Advisory's 13F filing for Q3 2026, filed 28 Oct 2026.